Limonene and carvacrol combined with drugs that inhibit ergosterol synthesis are potent against Leishmania major
Authors:
Open Access
- 16 March 2026
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (8) , 12599-12612
Abstract
Leishmaniases are neglected diseases widely distributed in tropical and subtropical countries, caused by parasites of the Leishmania genus. Current therapy includes pentavalent antimonial and amphotericin B, but adverse effects persist. The development of a new, more selective, and less toxic combination therapy is therefore a rational and promising approach. In this study, we report the effects of combinations of the monoterpenes limonene (Lim) and carvacrol (Car) with drugs targeting ergosterol biosynthesis, namely nystatin (Nys), tioconazole (Tio), and rosuvastatin (Ros), on Leishmania major , their cytotoxicity on macrophages, and we evaluate their synergism and mechanisms of action. The combinations inhibited the growth of L. major promastigotes, with Lim-Car combined with nystatin (3:2) exhibiting the highest activity, showing an IC 50 of 2.02 µg/mL. Furthermore, this combination demonstrated greater action against amastigotes (IC 50 of 0.53 µg/mL) and a high selectivity index (33.60). Low cytotoxicity was observed in murine macrophages (CC 50 17.81 µg/mL), as well as a low hemolytic potential (CH 50 of > 100 µg/mL). The Lim-Car and nystatin (3:2) combination presented a synergistic effect, with a fractional inhibitory concentration index of 0.4. Changes in parasite membrane integrity were also observed, which may be linked to the interaction of nystatin with the enzyme 14-alpha demethylase, along with an increase in TNF-α expression and a reduction in IL-10 and IL-6 levels. These results suggest that the combination of Lim-Car with Nys (3:2) may exert a summative effect through multiple biochemical pathways and warrants further investigation as a potential combined therapy with antileishmanial activity.Keywords
Funding Information
- Universidade Federal do Piauí
This publication has 30 references indexed in Scilit:
- Sulfonamide-chalcone hybrid compound suppresses cellular adhesion and migration: Experimental and computational insightChemico-Biological Interactions, 2024
- Dietary polysaccharides from guavira pomace, a co-product from the fruit pulp industry, display therapeutic application in gut disordersFood Research International, 2022
- Anti-Leishmania activity of artesunate and combination effects with amphotericin B against Leishmania (Mundinia) martiniquensis in vitroActa Tropica, 2022
- Need for sustainable approaches in antileishmanial drug discoveryParasitology Research, 2019
- Gallic and ellagic acids: two natural immunomodulator compounds solve infection of macrophages by Leishmania majorNaunyn-Schmiedeberg's Archives of Pharmacology, 2017
- Combinations of ascaridole, carvacrol, and caryophyllene oxide against LeishmaniaActa Tropica, 2015
- Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotesActa Tropica, 2014
- Molluscicidal and Leishmanicidal Activity of the Leaf Essential Oil of Syzygium cumini (L.) Skeels from BrazilChemistry & Biodiversity, 2013
- Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivoInternational Journal of Antimicrobial Agents, 2007
- Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasisActa Tropica, 2004